Neurological Emergencies Treatment Trials Network   Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2006
NCT00235495
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Neurological Emergencies Treatment Trials Network (NETT)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Injuries (Phase 3)

Brain Injuries, Traumatic (Phase 3)

Cerebral Infarction (Phase 3)

Hyperglycemia (Phase 3)

Ischemia (Phase 3)

Ischemic Attack, Transient (Phase 3)

Stroke (Phase 3)

Wounds and Injuries (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 4